Literature DB >> 24659790

Hepatitis C virus (HCV)-induced suppressor of cytokine signaling (SOCS) 3 regulates proinflammatory TNF-α responses.

Aideen S Collins1, Suaad Ahmed1, Silvia Napoletano1, Martina Schroeder2, James A Johnston3, John E Hegarty4, Cliona O'Farrelly5, Nigel J Stevenson6.   

Abstract

TNF-α is a proinflammatory cytokine, dramatically elevated during pathogenic infection and often responsible for inflammation-induced disease pathology. SOCS proteins are inhibitors of cytokine signaling and regulators of inflammation. In this study, we found that both SOCS1 and SOCS3 were transiently induced by TNF-α and negatively regulate its NF-κB-mediated signal transduction. We discovered that PBMCs from HCV-infected patients have elevated endogenous SOCS3 expression but less TNF-α-mediated IκB degradation and proinflammatory cytokine production than healthy controls. HCV protein expression in Huh7 hepatocytes also induced SOCS3 and directly inhibited TNF-α-mediated IL-8 production. Furthermore, we found that SOCS3 associates with TRAF2 and inhibits TRAF2-mediated NF-κB promoter activity, suggesting a mechanism by which SOCS3 inhibits TNF-α-mediated signaling. These results demonstrate a role for SOCS3 in regulating proinflammatory TNF-α signal transduction and reveal a novel immune-modulatory mechanism by which HCV suppresses inflammatory responses in primary immune cells and hepatocytes, perhaps explaining mild pathology often associated with acute HCV infection.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  hepatocytes; inflammation; peripheral blood mononuclear cells; signal transduction; viral infection

Mesh:

Substances:

Year:  2014        PMID: 24659790     DOI: 10.1189/jlb.2A1211-608RRRR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  21 in total

1.  DNA methylation analysis of SOCS1, SOCS3, and LINE-1 in microdissected gingival tissue.

Authors:  Denise C Andia; Aline C Planello; Danielle Portinho; Rodrigo A da Silva; Cristiane R Salmon; Enilson A Sallum; Francisco H Nociti Junior; Ana P de Souza
Journal:  Clin Oral Investig       Date:  2015-04-07       Impact factor: 3.573

Review 2.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

3.  Upregulation of suppressor of cytokine signaling 3 ameliorates spinal degenerative disease in adolescents by mediating leptin and tumor necrosis factor-α levels.

Authors:  Xiao-Ming Tang; Jian Dai; Hai-Lang Sun
Journal:  Exp Ther Med       Date:  2019-07-17       Impact factor: 2.447

4.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

5.  A novel anti-viral role for STAT3 in IFN-α signalling responses.

Authors:  Rebecca Mahony; Siobhán Gargan; Kim L Roberts; Nollaig Bourke; Sinead E Keating; Andrew G Bowie; Cliona O'Farrelly; Nigel J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-12-17       Impact factor: 9.207

6.  SOCS3 mRNA expression and polymorphisms as pretreatment predictor of response to HCV genotype 3a IFN-based treatment.

Authors:  Rabia Aslam; Syed Mohsin Raza; Humeira Naeemi; Bushra Mubarak; Nadeem Afzal; Saba Khaliq
Journal:  Springerplus       Date:  2016-10-21

7.  Suppressor of cytokine signaling 3 plays an important role in porcine circovirus type 2 subclinical infection by downregulating proinflammatory responses.

Authors:  Xuejiao Zhu; Juan Bai; Panrao Liu; Xianwei Wang; Ping Jiang
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

8.  IL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever.

Authors:  Lilian Karem Flores-Mendoza; Tania Estrada-Jiménez; Virginia Sedeño-Monge; Margarita Moreno; María Del Consuelo Manjarrez; Guadalupe González-Ochoa; Lourdes Millán-Pérez Peña; Julio Reyes-Leyva
Journal:  Mediators Inflamm       Date:  2017-07-30       Impact factor: 4.711

9.  Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses.

Authors:  Ping Meng; Suxian Zhao; Xuemin Niu; Na Fu; Shanshan Su; Rongqi Wang; Yuguo Zhang; Liang Qiao; Yuemin Nan
Journal:  Int J Mol Sci       Date:  2016-07-15       Impact factor: 5.923

10.  Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection.

Authors:  Stephanie C Burke Schinkel; Lorna Carrasco-Medina; Curtis L Cooper; Angela M Crawley
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.